131 related articles for article (PubMed ID: 27391350)
1. A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia.
Jeyaraju DV; Hurren R; Wang X; MacLean N; Gronda M; Shamas-Din A; Minden MD; Giaever G; Schimmer AD
Oncotarget; 2016 Aug; 7(31):49777-49785. PubMed ID: 27391350
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitochondrial RNA polymerase in acute myeloid leukemia.
Bralha FN; Liyanage SU; Hurren R; Wang X; Son MH; Fung TA; Chingcuanco FB; Tung AY; Andreazza AC; Psarianos P; Schimmer AD; Salmena L; Laposa RR
Oncotarget; 2015 Nov; 6(35):37216-28. PubMed ID: 26484416
[TBL] [Abstract][Full Text] [Related]
3. Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft.
Lee WJ; Hsiao M; Chang JL; Yang SF; Tseng TH; Cheng CW; Chow JM; Lin KH; Lin YW; Liu CC; Lee LM; Chien MH
Arch Toxicol; 2015 Jul; 89(7):1103-17. PubMed ID: 25138434
[TBL] [Abstract][Full Text] [Related]
4. Azelaic Acid Exerts Antileukemia Effects against Acute Myeloid Leukemia by Regulating the Prdxs/ROS Signaling Pathway.
Zhang D; Luo Z; Jin Y; Chen Y; Yang T; Yang Q; Wu B; Shang Y; Liu X; Wei Y; Zhou F
Oxid Med Cell Longev; 2020; 2020():1295984. PubMed ID: 33425206
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.
Di Marcantonio D; Martinez E; Sidoli S; Vadaketh J; Nieborowska-Skorska M; Gupta A; Meadows JM; Ferraro F; Masselli E; Challen GA; Milsom MD; Scholl C; Fröhling S; Balachandran S; Skorski T; Garcia BA; Mirandola P; Gobbi G; Garzon R; Vitale M; Sykes SM
Clin Cancer Res; 2018 Feb; 24(3):608-618. PubMed ID: 29127121
[No Abstract] [Full Text] [Related]
6. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
[TBL] [Abstract][Full Text] [Related]
7. MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Wang CC; Liu HE; Lee YL; Huang YW; Chen YJ; Liou JP; Huang HM
Tumour Biol; 2016 May; 37(5):6065-72. PubMed ID: 26608370
[TBL] [Abstract][Full Text] [Related]
8. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.
Bai LY; Weng JR; Chiu CF; Wu CY; Yeh SP; Sargeant AM; Lin PH; Liao YM
Biochem Pharmacol; 2013 Nov; 86(10):1430-40. PubMed ID: 24041743
[TBL] [Abstract][Full Text] [Related]
9. VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines.
Kurozumi N; Tsujioka T; Ouchida M; Sakakibara K; Nakahara T; Suemori SI; Takeuchi M; Kitanaka A; Shibakura M; Tohyama K
Cancer Sci; 2021 Aug; 112(8):3302-3313. PubMed ID: 34032336
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel Nrf2 inhibitor that induces apoptosis of human acute myeloid leukemia cells.
Zhang J; Su L; Ye Q; Zhang S; Kung H; Jiang F; Jiang G; Miao J; Zhao B
Oncotarget; 2017 Jan; 8(5):7625-7636. PubMed ID: 28032588
[TBL] [Abstract][Full Text] [Related]
11. 4'-O-Methylbroussochalcone B as a novel tubulin polymerization inhibitor suppressed the proliferation and migration of acute myeloid leukaemia cells.
Liu Z; Wang C; Wang Y; Wang L; Zhang Y; Yan G
BMC Cancer; 2021 Jan; 21(1):91. PubMed ID: 33482772
[TBL] [Abstract][Full Text] [Related]
12. Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.
Garcia JS; Huang M; Medeiros BC; Mitchell BS
Clin Cancer Res; 2016 Apr; 22(8):1978-88. PubMed ID: 26634271
[TBL] [Abstract][Full Text] [Related]
13. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
[TBL] [Abstract][Full Text] [Related]
14. The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs.
Bossis G; Sarry JE; Kifagi C; Ristic M; Saland E; Vergez F; Salem T; Boutzen H; Baik H; Brockly F; Pelegrin M; Kaoma T; Vallar L; Récher C; Manenti S; Piechaczyk M
Cell Rep; 2014 Jun; 7(6):1815-23. PubMed ID: 24910433
[TBL] [Abstract][Full Text] [Related]
15. Requirement of reactive oxygen species generation in apoptosis of leukemia cells induced by 2-methoxyestradiol.
She MR; Li JG; Guo KY; Lin W; Du X; Niu XQ
Acta Pharmacol Sin; 2007 Jul; 28(7):1037-44. PubMed ID: 17588341
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of WYE-687, a mTOR kinase inhibitor, as a potential anti-acute myeloid leukemia agent.
Cheng F; Wang L; Shen Y; Xia J; Chen H; Jiang Y; Lu M
Biochem Biophys Res Commun; 2016 Feb; 470(2):324-330. PubMed ID: 26792718
[TBL] [Abstract][Full Text] [Related]
17. Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells.
Rubio S; Quintana J; Eiroa JL; Triana J; Estévez F
Mol Carcinog; 2010 Jan; 49(1):32-43. PubMed ID: 19676104
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of c-Myc determines sensitivity to 2-methoxyestradiol-induced apoptosis in human acute myeloid leukemia.
Chow JM; Liu CR; Lin CP; Lee CN; Cheng YC; Lin S; Liu HE
Exp Hematol; 2008 Feb; 36(2):140-8. PubMed ID: 18206725
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
Kong X; Luo J; Xu T; Zhou Y; Pan Z; Xie Y; Zhao L; Lu Y; Han X; Li Z; Liu L
Oncol Rep; 2017 Jun; 37(6):3423-3432. PubMed ID: 28498435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]